Pfizer

Johnson & Johnson drops PurTox

Johnson & Johnson drops PurTox

By Andrew MCDOUGALL

The company as a whole may have reported strong first quarter results, but Johnson & Johnson has ended efforts to rival Allergan’s popular Botox anti-wrinkle treatment.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers